BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23299779)

  • 1. Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma.
    Schoof N; Franklin J; Fürst R; Zander T; von Bonin F; Peyrade F; Trümper L; Diehl V; Engert A; Kube D; Re D
    Oncologist; 2013; 18(1):80-9. PubMed ID: 23299779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study.
    Schoof N; von Bonin F; König IR; Mössner R; Krüger U; Reich K; Berking C; Volkenandt M; Ziegler A; Böckmann L; Kuschal C; Thoms KM; Kube D; Emmert S
    Genes Immun; 2009 Sep; 10(6):586-90. PubMed ID: 19458621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia.
    Hee CS; Gun SC; Naidu R; Gupta E; Somnath SD; Radhakrishnan AK
    Mod Rheumatol; 2007; 17(5):429-35. PubMed ID: 17929139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma.
    Hohaus S; Giachelia M; Di Febo A; Martini M; Massini G; Vannata B; D'Alo' F; Guidi F; Greco M; Pierconti F; Larocca LM; Voso MT; Leone G
    Ann Oncol; 2007 Aug; 18(8):1376-81. PubMed ID: 17496310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial.
    Schoof N; von Bonin F; Zeynalova S; Ziepert M; Jung W; Loeffler M; Pfreundschuh M; Trümper L; Kube D
    Ann Oncol; 2009 Sep; 20(9):1548-1554. PubMed ID: 19515749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma.
    Hohaus S; Giachelia M; Massini G; Vannata B; Criscuolo M; Martini M; D'Alo' F; Voso MT; Larocca LM; Leone G
    Leuk Res; 2009 Oct; 33(10):1352-6. PubMed ID: 19201467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.
    Kube D; Hua TD; Klöss M; Kulle B; Brockmöller J; Wojnowski L; Löffler M; Pfreundschuh M; Trümper L
    Genes Immun; 2007 Mar; 8(2):164-7. PubMed ID: 17215862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 gene promoter and intron polymorphisms and changes in IL-10 secretion in women with idiopathic recurrent miscarriage.
    Qaddourah RH; Magdoud K; Saldanha FL; Mahmood N; Mustafa FE; Mahjoub T; Almawi WY
    Hum Reprod; 2014 May; 29(5):1025-34. PubMed ID: 24626804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma.
    Gaiolla RD; Moraes MPT; de Oliveira DE
    PLoS One; 2021; 16(3):e0248259. PubMed ID: 33684151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma.
    da Silva GN; Bacchi MM; Rainho CA; de Oliveira DE
    Arch Pathol Lab Med; 2007 Nov; 131(11):1691-6. PubMed ID: 17979488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma.
    Munro LR; Johnston PW; Marshall NA; Canning SJ; Hewitt SG; Tveita K; Vickers MA
    Leuk Lymphoma; 2003 Dec; 44(12):2083-8. PubMed ID: 14959851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms and haplotype analysis of IL-4Ralpha Q576R and I75V in patients with penicillin allergy.
    Huang CZ; Yang J; Qiao HL; Jia LJ
    Eur J Clin Pharmacol; 2009 Sep; 65(9):895-902. PubMed ID: 19421745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-10 gene polymorphism is associated with preschool atopy and early-life recurrent wheezing after bronchiolitis in infancy.
    Korppi M; Nuolivirta K; Lauhkonen E; Holster A; Teräsjärvi J; Vuononvirta J; Helminen M; He Q; Koponen P
    Pediatr Pulmonol; 2017 Jan; 52(1):14-20. PubMed ID: 27228545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.
    Zidi S; Gazouani E; Stayoussef M; Mezlini A; Ahmed SK; Yacoubi-Loueslati B; Almawi WY
    Cytokine; 2015 Dec; 76(2):343-347. PubMed ID: 26076679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma.
    Yri OE; Ekstrøm PO; Hilden V; Gaudernack G; Liestøl K; Smeland EB; Holte H
    Leuk Lymphoma; 2012 Oct; 53(10):1934-44. PubMed ID: 22475179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Trümper LH; von Bonin F; Kapp U; Patterson B; Snow BE; Mak TW
    Blood; 2001 Jan; 97(1):250-5. PubMed ID: 11133768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene polymorphisms of interleukin-10 and transforming growth factor beta in allergic rhinitis.
    Nasiri R; Hirbod-Mobarakeh A; Movahedi M; Farhadi E; Ansaripour B; Amirzargar AA; Rezaei N
    Allergol Immunopathol (Madr); 2016; 44(2):125-30. PubMed ID: 26316419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk profiles in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damages related complications.
    Forte GI; Pilato G; Vaccarino L; Sanacore M; Candore G; Romano GC; Testa R; Franceschi C; Capri M; Marra M; Bonfigli AR; Caruso C; Scola L; Lio D
    Curr Pharm Des; 2010; 16(7):898-903. PubMed ID: 20388104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative IL-10 Low Producer Genotypes Are Associated with a Favourable Etanercept Response in Patients with Rheumatoid Arthritis.
    Schotte H; Schlüter B; Schmidt H; Gaubitz M; Drynda S; Kekow J; Willeke P
    PLoS One; 2015; 10(6):e0130907. PubMed ID: 26107717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.